pe
pep-05081 v1 CC-BY-SA-4.0

Neuromedin-S blood-sugar peptide

An experimental short peptide that switches on the same body sensor as Ozempic to help lower blood sugar; not an approved drug.

statuscomputed targetGLP-1R length36 aa refs2
metabolic
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 1.0
ipTM0.768
pTM0.794
avg pLDDT71.6
ranking score0.727
STRUCTURE · PEP-05081 × GLP-1R
ranking0.727
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence36 aa
1510152025303536
LPRLLRLDSRMATVDFPK KDPTTSLGRPFFLFRPRN
in the news 136 articles
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.7676040530204773 boltz-2
ranking score 0.7266835570335388 boltz-2
structural qualityopenfold3
metricvaluenote
gpde0.960global PDE — lower = better
disorderNaNfraction disordered
3-letter notation
Leu-Pro-Arg-Leu-Leu-Arg-Leu-Asp-Ser-Arg-Met-Ala-Thr-Val-Asp-Phe-Pro-Lys-Lys-Asp-Pro-Thr-Thr-Ser-Leu-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategynone
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-24
citationbibtex
peptidemodel (2026). Neuromedin-S blood-sugar peptide (pep-05081, v1). PeptideModel. https://peptidemodel.com/card/pep-05081
@peptide{pep05081,
  sequence = {LPRLLRLDSRMATVDFPKKDPTTSLGRPFFLFRPRN},
  target   = {glp-1r},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 5 by signal overlap
references 2 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use